XML 44 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Instruments Measured at Fair Value (Tables)
 9 Months Ended
Sep. 28, 2019
Fair Value Disclosures  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at September 28, 2019:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
19,847

 
$
—

 
$
—

 
$
19,847

Equity investments (b)
 
Other assets
 
43,071

 
—

 
—

 
43,071

Interest rate swaps
 
Other liabilities
 
—

 
(21,534
)
 
—

 
(21,534
)
Foreign exchange contracts
 
Other current assets/
other assets
 
—

 
30,533

 
—

 
30,533

Foreign exchange contracts
 
Accrued expenses
 
—

 
(1,431
)
 
—

 
(1,431
)
 
 
 
 
$
62,918

 
$
7,568

 
$
—

 
$
70,486


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2018:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
22,883

 
$
—

 
$
—

 
$
22,883

Equity investments (b)
 
Other assets
 
38,045

 
—

 
—

 
38,045

Interest rate swaps
 
Other liabilities
 
—

 
(589
)
 
—

 
(589
)
Foreign exchange contracts
 
Other current assets
 
—

 
4,163

 
—

 
4,163

Foreign exchange contracts
 
Accrued expenses
 
—

 
(2,384
)
 
—

 
(2,384
)
 
 
 
 
$
60,928

 
$
1,190

 
$
—

 
$
62,118



(a)
Cash equivalents include highly liquid investments with an original maturity of less than three months.
(b)
The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. The company recorded an unrealized gain of $378 and $2,220 for the third quarter and nine months ended September 28, 2019, respectively, on equity securities held at the end of the quarter. The company recorded an unrealized gain of $272 and an unrealized loss of $6,971 for the third quarter and nine months ended September 29, 2018, respectively, on equity securities held at the end of the quarter.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effects of derivative instruments on the company’s consolidated statements of operations and other comprehensive income are as follows:
  
 
Quarter Ended
 
Nine Months Ended
 
 
September 28,
2019

September 29,
2018
 
September 28,
2019
 
September 29,
2018
Gain (Loss) Recognized in Income
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
7,642

 
$
3,565

 
$
11,905

 
$
4,083

Interest rate swaps
 
(327
)
 
(311
)
 
(968
)
 
(922
)
Total
 
$
7,315

 
$
3,254

 
$
10,937

 
$
3,161

Gain (Loss) Recognized in Other Comprehensive Loss before reclassifications, net of tax
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
13,248

 
$
(1,212
)
 
$
20,495

 
$
(2,348
)
Interest rate swaps
 
(9,360
)
 
—

 
(16,209
)
 
—

Total
 
$
3,888

 
$
(1,212
)
 
$
4,286

 
$
(2,348
)
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]  
Fair Value Disclosures  
Description of Derivative Hedging Instruments
During the first quarter of 2019, the company entered into a series of foreign exchange contracts to sell Euro and buy United States Dollars, with various maturity dates as noted in the table below:
Maturity Date
 
Notional Amount
March 2023
 
EUR 50,000
September 2024
 
EUR 50,000
April 2025
 
EUR 100,000
January 2028
 
EUR 100,000
Total
 
EUR 300,000
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]  
Fair Value Disclosures  
Description of Derivative Hedging Instruments

As of September 28, 2019 and December 31, 2018, the company had one outstanding interest rate swap designated as a fair value hedge, the terms of which are as follows:
Maturity Date
 
Notional Amount
 
Interest rate due from counterparty
 
Interest rate due to counterparty
April 2020
 
50,000
 
6.000%
 
6 mo. USD LIBOR + 3.896%